Skip to content

Incidence of symptomatic meibomian gland dysfunction and characteristics of meibomian gland after cataract surgery

Incidence of symptomatic meibomian gland dysfunction and characteristics of meibomian gland after cataract surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20240527005
Enrollment
77
Registered
2024-05-27
Start date
2023-11-25
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Symptomatic meibomian gland dysfunction after cataract surgery Cataract surgery, meibomian gland dysfunction, phacoemulsification

Interventions

Asymptomatic MGD patients undergoing cataract surgery
Health Services Research
Asymptomatic MGD patients

Sponsors

Chulalongkorn university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Able to read, understand and sign an informed consent form 2.Able and willing to comply with the follow-up schedule and requirements 3.Patients diagnosed with cataracts with an indication for cataract surgery

Exclusion criteria

Exclusion criteria: 1.Preexisting symptomatic meibomian gland dysfunction 2.Complicated cataract surgery 3.Other ocular surface diseases 4.Patients who had used artificial tears within the past 1 week or topical medication to treat another ocular disease or systemic drugs that were known to affect the tear film and ocular surface 5.History of lid spa in the past 1 week 6.History of ocular trauma, ocular surgery, and ocular infection in the past 3 months, except for those causing permanent damage to the ocular surface 7.Contact lens wearer 8.Pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
Incidence of symptomatic MGD at 1 months after cataract surgery Incidence

Secondary

MeasureTime frame
Dry eye symptoms at 1 and 3 months after cataract surgery OSDI scores,Meibum quality at 1 and 3 months after cataract surgery according to the International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Management and Treatment of Meibomian Gland Dysfunction,Meibum expressibility at 1 and 3 months after cataract surgery according to the International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Management and Treatment of Meibomian Gland Dysfunction,Lipid layer thickness at 1 and 3 months after cataract surgery LipiView interferometer,5. Lid margin abnormalities at 1 and 3 months after cataract surgery according to the International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Management and Treatment of Meibomian Gland Dysfunction,superior and inferior lid meibography grade at 1 and 3 months after cataract surgery Keratograph 5M,NIBUT at 1 and 3 months after cataract surgery Keratograph 5M,Tear meniscus height at 1 and 3 months after cataract surgery Keratograph 5M,Ocular surface staining at 1 and 3 months after cataract surgery Oxford scheme

Countries

Thailand

Contacts

Public ContactNgamjit Kasetsuwan

Faculty of Medicine Chulalongkorn University

ngamjitk@gmail.com022564000

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026